This inventor holds 1 USPTO granted patent. Top assignee: Revagenix, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: John Knox - Innovator in Aminoglycoside Compounds
Introduction
John Knox is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of aminoglycoside compounds. His work focuses on creating therapeutic agents that can effectively combat bacterial infections.
Latest Patents
John Knox holds a patent for "Aminoglycosides and uses thereof." This patent includes aminoglycoside compounds, such as those represented by formulas (I), (II), (III), (IV), (IVa), (V), (VI), (VIIa), or (VIIb), along with their pharmaceutically acceptable salts, solvates, stereoisomers, or tautomers. These compounds are particularly useful in treating Gram-negative bacterial infections, providing a valuable tool in modern medicine.
Career Highlights
John Knox is currently employed at Revagenix, Inc., where he continues to innovate in the pharmaceutical sector. His work has led to advancements in the treatment of bacterial infections, showcasing his commitment to improving healthcare outcomes.
Collaborations
Throughout his career, John has collaborated with talented individuals such as Andrew Calabrese and Ryan Cirz. These partnerships have fostered a creative environment that encourages the development of groundbreaking solutions in the field of pharmaceuticals.
Conclusion
John Knox's contributions to the field of aminoglycoside compounds highlight his role as an influential inventor. His work not only advances scientific knowledge but also has the potential to improve patient care significantly.